Literature DB >> 4826569

Antibody-mediated in vivo suppression of EL4 leukemia in a syngeneic host.

J Zighelboim, B Bonavida, J L Fahey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4826569     DOI： 10.1093/jnci/52.3.879

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  Mechanisms of specific and non-specific tumour immunity after azathioprine treatment of mice.

Authors:  E C Purves
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

2.  Inhibition of a mouse hepatoma by the alkylating agent Trenimon linked to immunoglobulins.

Authors:  T Ghose; A Guclu; R R Raman; A H Blair
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

3.  Isoantiserum-augmented development of lymphocyte-mediated cytotoxicity.

Authors:  R Faanes; M Walker; Y S Choi
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

4.  Antibody-mediated suppression of grafted lymphoma. IV. Influence of time of tumor residency in vivo and tumor size upon the effectiveness of suppression by syngeneic antibody.

Authors:  H S Shin; J S Economou; G R Pasternack; R J Johnson; M L Hayden
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

5.  Antibody-induced changes in levels of cyclic adenosine monophosphate in leukaemic lymphocytes.

Authors:  M Virji; G T Stevenson
Journal:  Br J Cancer       Date:  1979-04       Impact factor: 7.640

6.  Activation of K cells in mice with transplanted tumours differing in immunogenicity and metastasizing capacity.

Authors:  A Mantovani; N Polentarutti; G Alessandri; A Vecchi; F Giuliani; F Spreafico
Journal:  Br J Cancer       Date:  1977-10       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.